Nubexa Retatrutide

Retatrutide (LY3437943) is a third-generation incretin research compound — the first triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. This represents the leading edge of metabolic peptide research.

— Mechanism Of Action

Retatrutide engages three distinct receptors: GLP-1 (insulin secretion, satiety), GIP (insulin response, lipid handling), and glucagon (energy expenditure, hepatic glucose). The glucagon component is particularly novel — counterintuitively, controlled glucagon agonism in this context appears to support energy expenditure research.

— Research Applications

Used in research investigating: triple-pathway metabolic signaling, energy expenditure mechanisms, comparative efficacy vs dual/single agonists, hepatic glucose research, lipid mobilization studies.

— Product Specifications

Compound	Retatrutide
Available Strengths	5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg
Purity	≥99% (verified by HPLC)
Form	Lyophilized powder
Storage	-20°C, protected from light
Reconstitution	Bacteriostatic water (sold separately)
Shelf Life	36 months (lyophilized, properly stored)
Certificate of Analysis	Available upon request — contact us

— What’s Included

Sealed lyophilized vial(s) of Retatrutide
Lot number and product information
Discreet, temperature-controlled packaging
Tracked international shipping

⚠ FOR RESEARCH USE ONLY
This product is sold strictly for laboratory research purposes. Not for human consumption, diagnosis, treatment, cure, or prevention of any disease. Not for use in food, cosmetics, household products, or as drugs. Must be 21 years or older to purchase. By placing this order you confirm that you are a qualified researcher or representative of a research organization purchasing this material exclusively for in vitro research applications.

— Mechanism Of Action

— Research Applications

— Product Specifications

— What’s Included

Reconstitution

Storage

Disclaimer